Videos / An update on semaglutide for CKD in the presence of T2D
In this Product Explainer, Endocrinologist Prof Richard MacIsaac provides an update on the chronic kidney disease (CKD) indication for semaglutide, explains the PBS criteria and how healthcare professionals can initiate this GLP-1 RA.

New Prostate Cancer Screening Guidelines – Case-Based Explanation for GP

Acute Migraine Management

Continuous Glucose Monitoring Update – Why it will Soon Become Standard Care

Faecal Calprotectin – A Practical Guide to the Test and the New Item Number

expert
Endocrinologist, Director, St Vincent’s Hospital Melbourne; Professor, University of Melbourne